Creation of a S1P Lyase bacterial surrogate for structure-based drug design-Reference-Cited by-同舟云学术

Creation of a S1P Lyase bacterial surrogate for structure-based drug design

Published:2016-05 Issue:9 Volume:26 Page:2293-2296
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Argiriadi Maria A.,Banach David,Radziejewska Elzbieta,Marchie Susan,DiMauro Jennifer,Dinges Jurgen,Dominguez Eric,Hutchins Charles,Judge Russell A.,Queeney Kara,Wallace Grier,Harris Christopher M.

Funder

AbbVie

U.S. Department of Energy

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference9 articles.

1. Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients

2. Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions

3. Inhibition of Sphingosine-1-Phosphate Lyase for the Treatment of Autoimmune Disorders

4. Orally Active 7-Substituted (4-Benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as Active-Site Inhibitors of Sphingosine 1-Phosphate Lyase for the Treatment of Multiple Sclerosis

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibiting sphingosine 1-phosphate lyase: From efficacy to mechanism;Neurobiology of Disease;2024-09

2. Functionalized 5‐Amino‐4‐cyanoxazoles, their Hetero‐ and Macrocyclic Derivatives: Preparation and Synthetic Applications;European Journal of Organic Chemistry;2021-06-07

3. l-Threonine Transaldolase Activity Is Enabled by a Persistent Catalytic Intermediate;ACS Chemical Biology;2020-12-18

4. Synthesis and Preliminary Exploration of Biological Activity of 3-Aryl-4-arylamine Methyl Isoxazoles;Chinese Journal of Organic Chemistry;2020

5. Sphingolipid biosynthesis in man and microbes;Natural Product Reports;2018